China issues first joint cartel and abuse fine to epinephrine maker

China’s competition authority has for the first time ever sanctioned a company for cartel conduct and abuse of dominance in a single case – slapping an active pharmaceutical ingredient supplier with a €37.7 million penalty.

Unlock unlimited access to all Global Competition Review content